These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21103274)

  • 1. Evaluation of Infliximab Effects on Gastrointestinal Bleeding in Crohn's Disease Using Double-Balloon Endoscopy.
    Chowdhury M; Kudara N; Chiba T; Endo M; Akasaka R; Tomita K; Fujiwara S; Mizutani T; Sugai T; Takikawa Y; Suzuki K
    Case Rep Gastroenterol; 2009 Jul; 3(2):193-197. PubMed ID: 21103274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
    Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
    Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of double-balloon endoscopy and an endoscopic scoring system to assess endoscopic remission in isolated small bowel Crohn's disease after treatment with infliximab.
    Han W; Hu J; Wu J; Zhang P; Liu Q; Hu N; Mei Q
    Therap Adv Gastroenterol; 2024; 17():17562848231224842. PubMed ID: 38250016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
    Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
    Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mucosal healing in different intestinal segments in patients receiving infliximab treatment for small bowel Crohn's disease].
    Zhu ZH; Qiu C; Zhang M; Chen Z; Xiang C; Wang XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):44-48. PubMed ID: 28109097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Bowel Healing Detected by Endoscopy in Patients With Crohn's Disease After Treatment With Antibodies Against Tumor Necrosis Factor.
    Takenaka K; Fujii T; Suzuki K; Shimizu H; Motobayashi M; Hibiya S; Saito E; Nagahori M; Watanabe M; Ohtsuka K
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1545-1552. PubMed ID: 31442600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal healing of Crohn's disease in a patient with concurrent systemic lupus erythematosus using infliximab.
    Kagaya Y; Sakamoto H; Yano T; Sunada K; Lefor AK; Niki T; Yamamoto H
    Clin J Gastroenterol; 2017 Jun; 10(3):244-249. PubMed ID: 28364315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated Infliximab Induction for Severe Lower Gastrointestinal Bleeding in a Young Patient with Crohn's Disease: A Case Report.
    Zeng J; Shen F; Fan JG; Ge WS
    World J Clin Cases; 2022 Jan; 10(2):733-740. PubMed ID: 35097101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.
    D'haens G; Van Deventer S; Van Hogezand R; Chalmers D; Kothe C; Baert F; Braakman T; Schaible T; Geboes K; Rutgeerts P
    Gastroenterology; 1999 May; 116(5):1029-34. PubMed ID: 10220494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of Crohn's disease under 
double balloon enteroscopy].
    Jia J; Liu R; Liu X; Shen S; Guo Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):494-499. PubMed ID: 29886464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
    Geboes K; Rutgeerts P; Opdenakker G; Olson A; Patel K; Wagner CL; Marano CW
    Curr Med Res Opin; 2005 Nov; 21(11):1741-54. PubMed ID: 16307694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
    D'Haens G; Vermeire S; Lambrecht G; Baert F; Bossuyt P; Pariente B; Buisson A; Bouhnik Y; Filippi J; Vander Woude J; Van Hootegem P; Moreau J; Louis E; Franchimont D; De Vos M; Mana F; Peyrin-Biroulet L; Brixi H; Allez M; Caenepeel P; Aubourg A; Oldenburg B; Pierik M; Gils A; Chevret S; Laharie D;
    Gastroenterology; 2018 Apr; 154(5):1343-1351.e1. PubMed ID: 29317275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
    de Bruyn M; Arijs I; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Vermeire S; Opdenakker G
    J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the diagnosis and treatment of small bowel lesions with Crohn's disease using double-balloon endoscopy.
    Sunada K; Yamamoto H; Yano T; Sugano K
    Therap Adv Gastroenterol; 2009 Nov; 2(6):357-66. PubMed ID: 21180582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients.
    Olbjørn C; Nakstad B; Småstuen MC; Thiis-Evensen E; Vatn MH; Perminow G
    Scand J Gastroenterol; 2014 Dec; 49(12):1425-31. PubMed ID: 25310799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflixmab as a possible treatment for the hemorrhagic type of Crohn's disease.
    Tsujikawa T; Nezu R; Andoh A; Saotome T; Araki Y; Ishizuka Y; Sasaki M; Koyama S; Fujiyama Y
    J Gastroenterol; 2004; 39(3):284-7. PubMed ID: 15065007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.